Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
VSTM

Verastem

$2.96

-0.08 (-2.63%)

05:50
04/09/18
04/09
05:50
04/09/18
05:50
Hot Stocks
Verastem says FDA accepts NDA for duvelisib, grants priority review »

Verastem announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$27.03

-0.22 (-0.81%)

, RVNC

Revance

$30.55

-0.05 (-0.16%)

04:55
03/28/18
03/28
04:55
03/28/18
04:55
Conference/Events
Needham to hold a conference »

Healthcare Conference to…

BSX

Boston Scientific

$27.03

-0.22 (-0.81%)

RVNC

Revance

$30.55

-0.05 (-0.16%)

MGEN

Miragen Therapeutics

$7.02

-0.49 (-6.52%)

AGLE

Aeglea BioTherapeutics

$9.21

-0.89 (-8.81%)

OMCL

Omnicell

$42.45

-0.45 (-1.05%)

AKBA

Akebia

$9.77

-0.805 (-7.61%)

TRVN

Trevena

$1.72

-0.04 (-2.27%)

PGNX

Progenics

$7.30

-0.04 (-0.54%)

LXRX

Lexicon

$8.18

-0.15 (-1.80%)

VSTM

Verastem

$3.06

-0.04 (-1.29%)

TTOO

T2 Biosystems

$6.24

-0.06 (-0.95%)

SRNE

Sorrento Therapeutics

$6.30

-0.7 (-10.00%)

XNCR

Xencor

$28.52

-2.56 (-8.24%)

VCEL

Vericel

$9.70

-0.5 (-4.90%)

ATHX

Athersys

$1.86

-0.06 (-3.13%)

COLL

Collegium Pharmaceutical

$26.44

-1.29 (-4.65%)

REPH

Recro Pharma

$10.86

-0.26 (-2.34%)

HSGX

Histogenics

CBIO

Catalyst Biosciences

$26.02

-1.77 (-6.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

  • 03

    Apr

  • 04

    Apr

  • 05

    Apr

  • 05

    Apr

  • 11

    Apr

  • 19

    Apr

  • 25

    Apr

  • 30

    Apr

  • 03

    May

  • 07

    May

  • 16

    May

  • 29

    May

  • 12

    Jun

  • 30

    Jul

BSX

Boston Scientific

$27.25

0.95 (3.61%)

, RVNC

Revance

$30.60

1.25 (4.26%)

08:19
03/27/18
03/27
08:19
03/27/18
08:19
Conference/Events
Needham to hold a conference »

Healthcare Conference to…

BSX

Boston Scientific

$27.25

0.95 (3.61%)

RVNC

Revance

$30.60

1.25 (4.26%)

MGEN

Miragen Therapeutics

$7.51

0.4 (5.63%)

AGLE

Aeglea BioTherapeutics

$10.10

-0.27 (-2.60%)

OMCL

Omnicell

$42.90

0.75 (1.78%)

AKBA

Akebia

$10.58

0.085 (0.81%)

TRVN

Trevena

$1.76

0.04 (2.33%)

PGNX

Progenics

$7.34

-0.2 (-2.65%)

LXRX

Lexicon

$8.33

0.28 (3.48%)

VSTM

Verastem

$3.10

-0.01 (-0.32%)

TTOO

T2 Biosystems

$6.30

-0.01 (-0.16%)

SRNE

Sorrento Therapeutics

$7.00

0.1 (1.45%)

XNCR

Xencor

$31.08

0.64 (2.10%)

VCEL

Vericel

$10.20

0.1 (0.99%)

ATHX

Athersys

$1.92

0.04 (2.13%)

COLL

Collegium Pharmaceutical

$27.73

1.19 (4.48%)

REPH

Recro Pharma

$11.12

0.31 (2.87%)

HSGX

Histogenics

$2.72

-0.1 (-3.55%)

CBIO

Catalyst Biosciences

$27.79

0.28 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 03

    Apr

  • 04

    Apr

  • 05

    Apr

  • 05

    Apr

  • 11

    Apr

  • 19

    Apr

  • 25

    Apr

  • 30

    Apr

  • 03

    May

  • 07

    May

  • 16

    May

  • 29

    May

  • 12

    Jun

  • 30

    Jul

Over a month ago
VSTM

Verastem

$3.55

0.1 (2.90%)

07:03
03/13/18
03/13
07:03
03/13/18
07:03
Earnings
Verastem reports FY17 net loss ($1.76), consensus ($1.74) »

As of December 31, 2017,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSTM

Verastem

$3.40

0.14 (4.29%)

04:50
03/08/18
03/08
04:50
03/08/18
04:50
Initiation
Verastem initiated at B. Riley FBR »

Verastem initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

VSTM

Verastem

$3.36

0.1 (3.07%)

07:08
02/07/18
02/07
07:08
02/07/18
07:08
Hot Stocks
Verastem submits NDA for Develisib to FDA »

Verastem announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSTM

Verastem

$3.40

0.17 (5.26%)

17:31
01/26/18
01/26
17:31
01/26/18
17:31
Hot Stocks
Breaking Hot Stocks news story on Verastem »

Biotechnology Value Fund…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSTM

Verastem

$3.23

-0.06 (-1.82%)

14:57
01/26/18
01/26
14:57
01/26/18
14:57
Hot Stocks
Verastem announces presentation of preclinical data on duvelisib combination »

Verastem announced that a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
VSTM

Verastem

$3.14

-0.07 (-2.18%)

07:09
01/04/18
01/04
07:09
01/04/18
07:09
Hot Stocks
Verastem names Joseph Lobacki as Chief Commercial Officer »

Verastem announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jan

VSTM

Verastem

$3.65

-0.15 (-3.95%)

09:01
12/15/17
12/15
09:01
12/15/17
09:01
Syndicate
Verastem 8.4M share Block Trade priced at $3.07 »

BTIG acted as sole book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.